Annual FCF
-$9.58 M
+$3.39 M+26.13%
December 31, 2023
Summary
- As of February 24, 2025, NDRA annual free cash flow is -$9.58 million, with the most recent change of +$3.39 million (+26.13%) on December 31, 2023.
- During the last 3 years, NDRA annual FCF has risen by +$1.24 million (+11.45%).
- NDRA annual FCF is now -881.33% below its all-time high of -$976.50 thousand, reached on December 31, 2015.
Performance
NDRA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.66 M
+$415.10 K+20.03%
September 30, 2024
Summary
- As of February 24, 2025, NDRA quarterly free cash flow is -$1.66 million, with the most recent change of +$415.10 thousand (+20.03%) on September 30, 2024.
- Over the past year, NDRA quarterly FCF has stayed the same.
Performance
NDRA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$8.08 M
+$941.60 K+10.43%
September 30, 2024
Summary
- As of February 24, 2025, NDRA TTM free cash flow is -$8.08 million, with the most recent change of +$941.60 thousand (+10.43%) on September 30, 2024.
- Over the past year, NDRA TTM FCF has stayed the same.
- NDRA TTM FCF is now -14922.86% below its all-time high of -$53.80 thousand, reached on March 31, 2016.
Performance
NDRA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NDRA Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +26.1% | 0.0% | 0.0% |
3 y3 years | +11.4% | 0.0% | 0.0% |
5 y5 years | -22.8% | 0.0% | 0.0% |
NDRA Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +26.1% | at high | +51.2% | at high | +37.7% |
5 y | 5-year | -11.0% | +26.1% | at high | +52.0% | at high | +37.7% |
alltime | all time | -881.3% | +26.1% | <-9999.0% | +52.0% | <-9999.0% | +37.7% |
ENDRA Life Sciences Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.66 M(-20.0%) | -$8.08 M(-10.4%) |
Jun 2024 | - | -$2.07 M(-4.6%) | -$9.02 M(-2.1%) |
Mar 2024 | - | -$2.17 M(-0.5%) | -$9.22 M(-3.8%) |
Dec 2023 | -$9.58 M(-26.1%) | -$2.18 M(-16.1%) | -$9.58 M(-9.0%) |
Sep 2023 | - | -$2.60 M(+14.6%) | -$10.53 M(-5.9%) |
Jun 2023 | - | -$2.27 M(-10.5%) | -$11.19 M(-9.1%) |
Mar 2023 | - | -$2.53 M(-19.0%) | -$12.32 M(-5.0%) |
Dec 2022 | -$12.97 M(+16.2%) | -$3.13 M(-4.1%) | -$12.97 M(+3.8%) |
Sep 2022 | - | -$3.26 M(-3.9%) | -$12.50 M(+4.3%) |
Jun 2022 | - | -$3.39 M(+6.5%) | -$11.98 M(+5.2%) |
Mar 2022 | - | -$3.19 M(+20.2%) | -$11.39 M(+2.0%) |
Dec 2021 | -$11.17 M(+3.2%) | -$2.65 M(-3.4%) | -$11.17 M(+4.8%) |
Sep 2021 | - | -$2.75 M(-1.9%) | -$10.65 M(+6.2%) |
Jun 2021 | - | -$2.80 M(-5.7%) | -$10.03 M(-6.1%) |
Mar 2021 | - | -$2.97 M(+38.8%) | -$10.68 M(-1.3%) |
Dec 2020 | -$10.82 M | -$2.14 M(+0.8%) | -$10.82 M(+1.8%) |
Sep 2020 | - | -$2.12 M(-38.5%) | -$10.63 M(-3.3%) |
Jun 2020 | - | -$3.45 M(+11.0%) | -$10.99 M(+19.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | -$3.11 M(+59.9%) | -$9.20 M(+6.5%) |
Dec 2019 | -$8.63 M(+10.6%) | -$1.95 M(-21.6%) | -$8.63 M(+0.5%) |
Sep 2019 | - | -$2.48 M(+49.7%) | -$8.59 M(+11.9%) |
Jun 2019 | - | -$1.66 M(-34.9%) | -$7.67 M(-2.8%) |
Mar 2019 | - | -$2.55 M(+33.8%) | -$7.90 M(+1.2%) |
Dec 2018 | -$7.80 M(+135.8%) | -$1.90 M(+21.3%) | -$7.80 M(+7.2%) |
Sep 2018 | - | -$1.57 M(-16.5%) | -$7.28 M(+16.3%) |
Jun 2018 | - | -$1.88 M(-23.3%) | -$6.25 M(+13.2%) |
Mar 2018 | - | -$2.45 M(+78.2%) | -$5.52 M(+67.0%) |
Dec 2017 | -$3.31 M(+151.5%) | -$1.38 M(+151.7%) | -$3.31 M(+33.5%) |
Sep 2017 | - | -$546.60 K(-52.5%) | -$2.48 M(+28.3%) |
Jun 2017 | - | -$1.15 M(+386.8%) | -$1.93 M(+29.0%) |
Mar 2017 | - | -$236.30 K(-56.7%) | -$1.50 M(+13.9%) |
Dec 2016 | -$1.32 M(+34.7%) | -$546.20 K(<-9900.0%) | -$1.32 M(+71.0%) |
Sep 2016 | - | $0.00(-100.0%) | -$769.50 K(0.0%) |
Jun 2016 | - | -$715.70 K(+1230.3%) | -$769.50 K(+1330.3%) |
Mar 2016 | - | -$53.80 K | -$53.80 K |
Dec 2015 | -$976.50 K(-41.6%) | - | - |
Dec 2014 | -$1.67 M | - | - |
FAQ
- What is ENDRA Life Sciences annual free cash flow?
- What is the all time high annual FCF for ENDRA Life Sciences?
- What is ENDRA Life Sciences annual FCF year-on-year change?
- What is ENDRA Life Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for ENDRA Life Sciences?
- What is ENDRA Life Sciences quarterly FCF year-on-year change?
- What is ENDRA Life Sciences TTM free cash flow?
- What is the all time high TTM FCF for ENDRA Life Sciences?
- What is ENDRA Life Sciences TTM FCF year-on-year change?
What is ENDRA Life Sciences annual free cash flow?
The current annual FCF of NDRA is -$9.58 M
What is the all time high annual FCF for ENDRA Life Sciences?
ENDRA Life Sciences all-time high annual free cash flow is -$976.50 K
What is ENDRA Life Sciences annual FCF year-on-year change?
Over the past year, NDRA annual free cash flow has changed by +$3.39 M (+26.13%)
What is ENDRA Life Sciences quarterly free cash flow?
The current quarterly FCF of NDRA is -$1.66 M
What is the all time high quarterly FCF for ENDRA Life Sciences?
ENDRA Life Sciences all-time high quarterly free cash flow is $0.00
What is ENDRA Life Sciences quarterly FCF year-on-year change?
Over the past year, NDRA quarterly free cash flow has changed by $0.00 (0.00%)
What is ENDRA Life Sciences TTM free cash flow?
The current TTM FCF of NDRA is -$8.08 M
What is the all time high TTM FCF for ENDRA Life Sciences?
ENDRA Life Sciences all-time high TTM free cash flow is -$53.80 K
What is ENDRA Life Sciences TTM FCF year-on-year change?
Over the past year, NDRA TTM free cash flow has changed by $0.00 (0.00%)